
Biorestorative Therapies (BRTX)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy Biorestorative Therapies (BRTX) Stock
Start investing in Biorestorative Therapies (BRTX)
About Biorestorative Therapies (BRTX)
Market cap | $11.93M |
Yesterday's volume | 76.77K |
Revenue (TTM) | $391K |
Avg. daily volume | 103.19K |
EBITDA (TTM) | -$12.06M |
Open | $1.64 |
Price / earnings ratio | -1.06x |
Yesterday's range | $1.57 - $1.65 |
Debt / equity | — |
52 week range | $1.21 - $2.55 |
5 year debt / equity | -68.83x |
Beta (LTM) | 1.23x |
Interest coverage | — |
Dividend & yield | $0.00 (0.00%) |
Current ratio | 2.23x |
Ex-dividend date | — |
Next earnings | Aug 12, 2025 |
Dividend payable date | — |
Biorestorative Therapies Stock Rating
Biorestorative Therapies Stock News
View all



Frequently Asked Questions (FAQ)
How to buy BRTX stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in BRTX stock
Navigate to the Explore page. Then, type BRTX into the search bar. When you see BRTX stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased BRTX stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Biorestorative Therapies Stock Earnings
The value each BRTX share was expected to gain vs. the value that each BRTX share actually gained.
Biorestorative Therapies (BRTX) reported Q1 2025 earnings per share (EPS) of -$0.64, missing estimates of -$0.32 by 100.00%. In the same quarter last year, Biorestorative Therapies's earnings per share (EPS) was -$0.33. Biorestorative Therapies is expected to release next earnings on 08/12/2025, with an earnings per share (EPS) estimate of -$0.41.